Doctors Without Borders (MSF)
About Us
MSF is a global network of principled medical and other professionals working in teams, small and large, to respond to the medical needs of people affected by conflict, disasters and epidemics and those excluded from healthcare.
Democratic Republic of Congo (DRC)
Patient and Staff Stories - 20 Jul 2020
Treating scabies – a forgotten disease in a forgotten corner of the world
Dr Alejandra Garcia Naranjo shares her experience in helping a boy who was infected with severe scabies.Patient and Staff Stories - 20 Jul 2020
Coronavirus COVID-19 pandemic
Patient and Staff Stories - 16 Jul 2020
AIDS has not disappeared: the reality of Advanced HIV disease in Nsanje, Malawi
Advanced HIV is still a reality for people in Nsanje in Malawi, even in the midst of COVID-19. MSF'S Health Policy Advisor, Drew Aiken gives an account of his experience in Nsanje.Patient and Staff Stories - 16 Jul 2020
Cameroon
MSF condemns the killing of a community health worker in South-West Cameroon
Press Release - 11 Jul 2020
Coronavirus COVID-19 pandemic
Fieldworkers Stories - 10 Jul 2020
Providing mental healthcare during COVID-19
Our Psychologist Cassandra Govender gives insight on what MSF is doing to help migrants access mental healthcare services during the COVID-19 pandemic in the Tshwane Migrant project in South Africa.Fieldworkers Stories - 10 Jul 2020
Coronavirus COVID-19 pandemic
Latest News - 10 Jul 2020
Supporting mental health during a pandemic
Mental healthcare is an important aspect of people's well being, our colleagues have had to adapt to how they treat patients during the COVID-19 pandemic.Latest News - 10 Jul 2020
Coronavirus COVID-19 pandemic
Press Release - 8 Jul 2020
International AIDS Society awards MSF work on differentiated HIV service delivery in Eshowe
Our organization donated R170793 cash prize to Shintsha Health Initiative to bolster support to people living with HIV, emphasising the need for adapted HIV services during COVID-19 pandemic.Press Release - 8 Jul 2020
Coronavirus COVID-19 pandemic
Press Release - 6 Jul 2020
J&J price reduction on key DR-TB drug important, governments should scale up treatment urgently
MSF has acknowledged a move by Johnson & Johnson to reduce the price of bedaquiline, one of the most effective drugs for drug-resistant forms of tuberculosis (DR-TB) as an important step that should allow more people to access this life-saving drug. But the price should come down further and be extended to more countries.Press Release - 6 Jul 2020